Olivier Tredan
ScholarGPS® ID: 36424811114557
Affiliation History
Field
Medicine
Discipline
Oncology
Top Specialties
Cancer | Breast Cancer | Metastatic Breast Cancer | Ovarian Cancer | Chemotherapy | Neoplasm | Physical Activity | Bevacizumab | Mutation | Genomics | Trastuzumab | Metabolomics | Adjuvant Therapy | BRCA2 | Lung Cancer
Metrics Summary
Publication Count
315
Predicted Citations
12,021
Predicted h-index
47
Ranking
Publications and Citation History
Publications based on Top Specialties
Types of Publication
- Publications
- Books
- Patents
- NIH/NSF
Add
Delete
|
---|
Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 12122-12122 (2024). |
Clinical utility of ctDNA as a tool to detect triple-negative breast cancer relapses: The CUPCAKE trial. (journal article) Journal of Clinical Oncology, volume 42, issue 16_suppl, pages TPS1139-TPS1139 (2024). |
251P Genomic alterations of breast cancer patients with leptomeningeal disease: A retrospective analysis (journal article) ESMO Open, volume 9 (2024). |
Added value of whole‐exome and RNA sequencing in advanced and refractory cancer patients with no molecular‐based treatment recommendation based on a 90‐gene panel (journal article) Cancer Medicine, volume 13, issue 7 (2024). |
Bevacizumab, olaparib, and durvalumab in patients with relapsed ovarian cancer: a phase II clinical trial from the GINECO group (journal article) Nature Communications, volume 15, issue 1 (2024). |
The French multicentric molecular analysis platforms and personalized medicine trials MOST, MOST Plus and MEGAMOST (journal article) Acta Oncologica, volume 63 (2023). |
MDR1-expressing CD4+ T cells with Th1.17 features resist to neoadjuvant chemotherapy and are associated with breast cancer clinical response (journal article) Journal for ImmunoTherapy of Cancer, volume 11, issue 11, pages e007733- (2023). |
The Lancet, volume 402, issue 10411, pages 1423-1433 (2023). |
145P Identification of biomarkers of survival across multiple cancer types using eXplainable artificial intelligence (journal article) Annals of Oncology, volume 34 (2023). |
PRMT5 triggers glucocorticoid-induced cell migration in triple-negative breast cancer (journal article) Life Science Alliance, volume 6, issue 10, pages e202302009- (2023). |
Do surgeons overestimate diaphragmatic peritoneal disease in interval debulking surgery of ovarian cancer? (journal article) European Journal of Surgical Oncology, volume 49, issue 9, pages 106963- (2023). |
Prise en charge des carcinomes à haut risque : quelles stratégies au-delà de la chimiothérapie ? (journal article) Innovations & Thérapeutiques en Oncologie, volume 9, issue S1, pages 18-22 (2023). |
EMBO Molecular Medicine, volume 15, issue 8 (2023). |
Cancer Medicine, volume 12, issue 16, pages 16889-16895 (2023). |
Large versus limited molecular profiling panel screening program in patients with metastatic sarcoma: An exploratory subgroup analysis from the ProfiLER 02 trial. (journal article) Journal of Clinical Oncology, volume 41, issue 16_suppl, pages 11545-11545 (2023). |
Journal of Clinical Oncology, volume 41, issue 16_suppl, pages 1003-1003 (2023). |
Splenectomy in epithelial ovarian cancer surgery (journal article) International Journal of Gynecologic Cancer, volume 33, issue 6, pages 944-950 (2023). |
International Journal of Clinical Oncology, volume 28, issue 3, pages 371-381 (2023). |
Utilisation des tests génomiques en oncologie : avis d’experts Français selon la méthode Delphi (journal article) Bulletin du Cancer, volume 110, issue 3, pages 320-330 (2023). |